, L. et al., International J. of
Pharmaceutics, 114, 141-149, (1995).
12. Perrin, J.H. and Saunders, L., Biochim. Biophys.
Acta., 84, 216-217 (1964).
13. Hayashi, H. et
, L. et al., International J. of
Pharmaceutics, 114, 141-149, (1995).
12. Perrin, J.H. and Saunders, L., Biochim. Biophys.
Acta., 84, 216-217 (1964).
13. Hayashi, H. et
, L. et al., International J. of
Pharmaceutics, 114, 141-149, (1995).
12. Perrin, J.H. and Saunders, L., Biochim. Biophys.
Acta., 84, 216-217 (1964).
13. Hayashi, H. et
, L. et al., International J. of
Pharmaceutics, 114, 141-149, (1995).
12. Perrin, J.H. and Saunders, L., Biochim. Biophys.
Acta., 84, 216-217 (1964).
13. Hayashi, H. et
, L. et al., International J. of
Pharmaceutics, 114, 141-149, (1995).
12. Perrin, J.H. and Saunders, L., Biochim. Biophys.
Acta., 84, 216-217 (1964).
13. Hayashi, H. et
, L. et al., International J. of
Pharmaceutics, 114, 141-149, (1995).
12. Perrin, J.H. and Saunders, L., Biochim. Biophys.
Acta., 84, 216-217 (1964).
13. Hayashi, H. et
, L. et al., International J. of
Pharmaceutics, 114, 141-149, (1995).
12. Perrin, J.H. and Saunders, L., Biochim. Biophys.
Acta., 84, 216-217 (1964).
13. Hayashi, H. et
, L. et al., International J. of
Pharmaceutics, 114, 141-149, (1995).
12. Perrin, J.H. and Saunders, L., Biochim. Biophys.
Acta., 84, 216-217 (1964).
13. Hayashi, H. et
, L. et al., International J. of
Pharmaceutics, 114, 141-149, (1995).
12. Perrin, J.H. and Saunders, L., Biochim. Biophys.
Acta., 84, 216-217 (1964).
13. Hayashi, H. et
Hovgaard, L. et al., International J. of
Pharmaceutics, 114, 141-149, (1995).
12. Perrin, J.H. and Saunders, L., Biochim. Biophys.
Acta., 84, 216-217 (1964).
13. Hayashi, H. et al., Chemistry Letters
, L. et al., International J. of
Pharmaceutics, 114, 141-149, (1995).
12. Perrin, J.H. and Saunders, L., Biochim. Biophys.
Acta., 84, 216-217 (1964).
13. Hayashi, H. et
, L. et al., International J. of
Pharmaceutics, 114, 141-149, (1995).
12. Perrin, J.H. and Saunders, L., Biochim. Biophys.
Acta., 84, 216-217 (1964).
13. Hayashi, H. et
, L. et al., International J. of
Pharmaceutics, 114, 141-149, (1995).
12. Perrin, J.H. and Saunders, L., Biochim. Biophys.
Acta., 84, 216-217 (1964).
13. Hayashi, H. et
, L. et al., International J. of
Pharmaceutics, 114, 141-149, (1995).
12. Perrin, J.H. and Saunders, L., Biochim. Biophys.
Acta., 84, 216-217 (1964).
13. Hayashi, H. et
-a (Ab-�) Mouse mAb
(189-21�0 .1)
NT human, rat GF15 100 µg €216
Anti-Transforming Growth Factor-a (Ab-�) Mouse mAb
(189-21�0 .1)
NT human, rat GF15L 100 µg €216
Anti-Transforming Growth Factor-b1
940 114
8 940 115
Working temperature ranges and specifications
For recirculating coolers °C -30 ... +80 -50 ... +105 -20 ... +180
Flash point °C -- +124 +190
Fire point °C -- +142 +216
Viscosity
in stress
and inflammatory responses, nuclear export, and cell
proliferation. Specific activity: ≥216 nmol/min/mg protein.
Purity: ≥90% by SDS-PAGE.
Cat. No. 475861 5 mg € 139
Ref.: McCormick, C .
group Open user&group setting window 215 NO NO NO NO NO YES
Backup&Restore 216-Backup&Restore Save, delete, restore back-up 216 NO NO NO NO NO YES
AI scale&filter 217-AI scale&filter Scale & filter analog